Literature DB >> 15833690

Acute intermittent porphyria.

Ariane L Herrick1, Kenneth E L McColl.   

Abstract

Acute intermittent porphyria (AIP) is characterised by neurovisceral crises the most common clinical presentation of which is abdominal pain. It is an autosomal dominant condition with incomplete penetrance and is potentially life-threatening. The key point in management is to suspect and confirm the diagnosis as early as possible in order to treat the attack and to avoid inappropriate treatments which may exacerbate the crisis. In this chapter we briefly outline the haem biosynthetic pathway and how deficiencies in individual enzymes give rise to the different porphyrias. We then describe the clinical features and diagnosis of AIP, followed by a discussion of pathogenesis, highlighting advances in the molecular biology of AIP and introducing the debate as to whether neurovisceral crises might result from porphyrin precursor neurotoxicity or from haem deficiency. Finally we discuss management, including family screening, avoidance of triggering factors, analgesia, maintenance of a high calorie intake, and administration of haem derivatives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833690     DOI: 10.1016/j.bpg.2004.10.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  17 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

2.  Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.

Authors:  Janice Andersen; Sverre Sandberg; Maalfrid Raaheim; Eva Gjengedal
Journal:  JIMD Rep       Date:  2011-06-22

Review 3.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

4.  Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate.

Authors:  Petra Melenovská; Jana Kopecká; Jakub Krijt; Aleš Hnízda; Kateřina Raková; Miroslav Janošík; Bridget Wilcken; Viktor Kožich
Journal:  J Inherit Metab Dis       Date:  2014-10-21       Impact factor: 4.982

Review 5.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

6.  A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.

Authors:  Dimitri Tchernitchko; Quentin Tavernier; Jérôme Lamoril; Caroline Schmitt; Neila Talbi; Said Lyoumi; Anne-Marie Robreau; Zoubida Karim; Laurent Gouya; Eric Thervet; Alexandre Karras; Hervé Puy; Nicolas Pallet
Journal:  J Am Soc Nephrol       Date:  2016-12-28       Impact factor: 10.121

7.  Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series.

Authors:  Barbara Willandt; Janneke G Langendonk; Katharina Biermann; Wouter Meersseman; François D'Heygere; Christophe George; Chris Verslype; Diethard Monbaliu; David Cassiman
Journal:  JIMD Rep       Date:  2015-06-21

Review 8.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

9.  Clinical Challenges of Acute Porphyria in the Young Adult.

Authors:  Shannon Burns; Allison Harmel; Sally Miller; Gabriela Figueiredo Pucci; Jonathan Greco; Michael Pulley; Michael Pizzi
Journal:  Neurohospitalist       Date:  2022-02-09

10.  Chronic elevation of liver enzymes in acute intermittent porphyria initially misdiagnosed as autoimmune hepatitis.

Authors:  A González Estrada; S García-Morillo; L Gómez Morales; P Stiefel García-Junco
Journal:  Int J Hepatol       Date:  2011-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.